medical-technology
(5)
The Biotech Fund That Put Scientists in the Investment Committee
Catalio built a $2 billion healthcare investment platform around a simple wager: the people who invent the science may also be the best people to interrogate it.
GE HealthCare
The 130-year medical-technology lineage is no longer selling scanners alone. Its bet is that imaging hardware, diagnostic drugs, cloud software and AI can work as one connected care system - without asking clinicians to become IT departments.
Siemens Healthineers
Its scanners see disease, its lab systems measure it, and its therapy platforms help treat it. Siemens Healthineers has quietly assembled one of healthcare's broadest portfolios - and a business model designed to remain in the hospital long after the machine arrives.
Revamp Medical
Revamp Medical is an Israeli medical device company building the Doraya catheter, a temporary, adjustable flow-reducing catheter for patients hospitalized with acute heart failure. Deployed in the infrarenal inferior vena cava for up to 12 hours, Doraya is designed to relieve venous congestion and improve response to diuretic therapy in patients who respond poorly to standard drugs - addressing the local mechanism of diuretic resistance rather than relying on systemic drugs or dialysis. Founded in 2016 and based in Netanya, the company won FDA Breakthrough Device designation in 2020 and closed a KCK Medtech-led Series A in 2023 to fund U.S. clinical trials.
Nventric, Inc.
Nventric, Inc. is a medical device company and contract development and manufacturing organization (CDMO) headquartered in Arcadia, California, with operations in Seoul, South Korea. Founded in 2019 by engineers with backgrounds at Abbott Vascular and Johnson & Johnson, Nventric designs and builds minimally invasive vascular devices - covering neurovascular, coronary, and electrophysiology applications - from concept through scalable, ISO 13485-certified manufacturing. Its own-branded neurovascular line, including the ULTRIVA stent retriever and EVOGLIDE distal access catheter, targets acute ischemic stroke, while its OEM/CDMO services help device companies move products from prototype to commercialization.